Literature DB >> 8645744

Development of plasma cell tumors during treatment of multiple myeloma.

G Vaiopoulos1, N Viniou, E Plata, K Konstantopoulos, A Andreopoulos, Y Rombos, J Meletis, D Loukopoulos, X Yataganas.   

Abstract

Plasma cell tumors (plasmacytomas-PCT) of the bone, or extramedullary PCT, may be diagnosed in patients with or without the diagnostic criteria for systemic multiple myeloma (MM). The reason for the local development of these tumors is not clear. Recent reports emphasize the contribution of CT and MRI in the detection of bone lesions and their expansion into the soft tissues. We report the development of PCT in nine patients with MM under maintenance treatment with alpha-IFN, of whom six had no evidence of systemic relapse and three had indications of early relapse. The PCT were located in the pelvis (4), thoracic (3), cervical (1), and lumbar (2) spine and in 8/9 cases were not demonstrable on plain X-rays. These observations suggest that frequent screening with advanced imaging techniques may detect local disease expansion in asymptomatic patients. Early application of radiochemotherapy may improve prognosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8645744     DOI: 10.1007/s002770050178

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  8 in total

Review 1.  Plasma cell myeloma--new biological insights and advances in therapy.

Authors:  B Barlogie; J Epstein; P Selvanayagam; R Alexanian
Journal:  Blood       Date:  1989-03       Impact factor: 22.113

2.  Recombinant interferon alfa-2b (Intron A) as post-induction therapy for responding multiple myeloma patients. M84 protocol.

Authors:  F Mandelli; M Tribalto; G Avvisati; M Cantonetti; M T Petrucci; M Boccadoro; A Pileri; F Marmont; L Resegotti; V Lauta
Journal:  Cancer Treat Rev       Date:  1988-01       Impact factor: 12.111

3.  'Role of bone marrow stromal cells in the growth of human multiple myeloma.

Authors:  F Caligaris-Cappio; L Bergui; M G Gregoretti; G Gaidano; M Gaboli; M Schena; A Z Zallone; P C Marchisio
Journal:  Blood       Date:  1991-06-15       Impact factor: 22.113

4.  Computed tomography in diagnosis and management of multiple myeloma and its variants.

Authors:  R A Kyle; J S Schreiman; R A McLeod; J W Beabout
Journal:  Arch Intern Med       Date:  1985-08

Review 5.  Staging and kinetics of multiple myeloma.

Authors:  B G Durie
Journal:  Clin Haematol       Date:  1982-02

6.  Influence of interferon on antibody production and viability of malignant cells from patients with multiple myeloma.

Authors:  D Grandér; L V von Stedingk; M von Stedingk; J Wasserman; S Einhorn
Journal:  Eur J Haematol       Date:  1991-01       Impact factor: 2.997

7.  Extraosseous multiple myeloma: imaging features.

Authors:  L A Moulopoulos; C A Granfield; M A Dimopoulos; E E Kim; R Alexanian; H I Libshitz
Journal:  AJR Am J Roentgenol       Date:  1993-11       Impact factor: 3.959

8.  Magnetic resonance imaging of the spine in multiple myeloma.

Authors:  H Ludwig; F Frühwald; D Tscholakoff; S Rasoul; A Neuhold; E Fritz
Journal:  Lancet       Date:  1987-08-15       Impact factor: 79.321

  8 in total
  2 in total

1.  An unusual presentation of a secondary extramedullary plasmacytoma in a patient with multiple myeloma.

Authors:  Martin Dzierzanowski; Geoffrey A Porter
Journal:  Can J Surg       Date:  2005-02       Impact factor: 2.089

2.  Secondary extramedullary plasmacytoma causing small bowel intussusception in a patient with multiple myeloma - A case report.

Authors:  Arun Ariyarathenam; Nick Galvin; Jacob A Akoh
Journal:  Int J Surg Case Rep       Date:  2013-03-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.